SCHEMBL14919221

SCHEMBL14919221

CCOC(=O)C(CO)CC(N)Cc1ccc(-c2ccccc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 10/20 0.52
▸ MEN1 O00255 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ ACE P12821 5/20 0.45
▸ SRR Q9GZT4 2/20 0.45
▸ PSAT1 Q9Y617 2/20 0.45
▸ PPARG P37231 2/20 0.44
▸ EPHX2 P34913 1/20 0.44
▸ GPR88 Q9GZN0 1/20 0.42
▸ MMP8 P22894 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CTSH P09668 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CTSK P43235 1/20 0.41
▸ CTSC P53634 1/20 0.41
▸ PPARA Q07869 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11969895 1.00 MME (0.52) MMEMEN1NPC1KMT2AACE
SCHEMBL18626432 0.90 MME (0.47) MMEMEN1NPC1KMT2AACE
SCHEMBL16930437 0.88 MME (0.48) MMEMEN1NPC1KMT2AACE
SCHEMBL16930474 0.88 MME (0.46) MMEMEN1NPC1KMT2AACE
SCHEMBL11969564 0.87 MME (0.69) MMEACEPPARGEPHX2GPR88
SCHEMBL16939264 0.87 MME (0.69) MMEACEPPARGEPHX2GPR88
SCHEMBL14890510 0.87 MME (0.48) MMEMEN1NPC1KMT2APPARG
SCHEMBL18597892 0.87 MME (0.48) MMEMEN1NPC1KMT2APPARG
SCHEMBL16930426 0.86 MME (0.59) MMEMEN1NPC1KMT2AACE
SCHEMBL18874737 0.85 MME (0.49) MMEMEN1NPC1KMT2ASRR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773335-A1 NEPRILYSIN INHIBITORS Theravance, Inc. (US) 2014-09-10 — — EP disclosed
WO-2013067163-A1 NEPRILYSIN INHIBITORS THERAVANCE, INC. (US) 2013-05-10 — — WO disclosed
Send feedback